View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form 13F-HR CITIGROUP INC For: Jun 30
-
Form 13F-NT Citigroup Global Markets For: Jun 30
-
Form 13F-NT Citigroup Global Markets For: Jun 30
-
Form 13F-NT Citigroup Global Markets For: Jun 30
-
Robinhood's second private markets fund targets $200 million US IPO
-
Form 424B2 CITIGROUP INC
-
Form 13F-NT Citigroup Global Markets For: Jun 30
-
Form 13F-NT Citigroup Global Markets For: Jun 30
-
Form 13F-NT Citigroup Financial Prod For: Jun 30
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Snowflake to Present at Upcoming Investor Conferences
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Robinhood Ventures Fund II launches IPO roadshow on NYSE
-
Robinhood Ventures Fund II (RVII) Announces Launch of Initial Public Offering
-
Brazil central bank to cut rates for fourth straight meeting on August 5: Reuters poll
-
Form 424B2 CITIGROUP INC
-
American Airlines and Citi update AAdvantage Executive card with new perks
-
American Airlines and Citi Elevate Premium Travel With Enhanced Citi / AAdvantage Executive World Legend Mastercard
-
Citi Adjusts Catalyst Watch List
-
Citi says buy these 3 chip stocks on pullback
-
Dylan Tornay Joins Evercore as Senior Managing Director in the Equity Capital Markets Group
-
Supernus and Indivior agree to all-stock merger of equals
-
KKR to acquire Integer Holdings in $5.7 billion all-cash deal
-
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
-
Integer to Be Acquired by KKR in Transaction Valued at Approximately $5.7 Billion
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B3 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.

